Seeking Alpha

CRIS
  Curis, Inc. - NASDAQ

11/28/2014, 6:06 PM ET
  • BTM | Send Message 19 Feb 2013

    Big move before earnings call in $CRIS. Hmm...
    Reply
      CRIS vs. ETF Alternatives
      Company Description
      Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States